# NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors

> **NCT00299728** · PHASE1 · COMPLETED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 22 (actual)

## Conditions studied

- Tumors

## Interventions

- **BIOLOGICAL:** NY-ESO-1 Protein Vaccine

## Key facts

- **NCT ID:** NCT00299728
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03-21
- **Primary completion:** 2006-10-10
- **Final completion:** 2014-01-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299728, "NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00299728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*